SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1961-01-01

Employees: -

Market Cap: -

Website: http://www.sbmu.ac.ir/

Clinical Trials

Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy

Phase 1

Conditions: Wound Healing
Pain

Interventions: Drug: Phenytoin paste
Drug: Placebo

First Posted Date: 2012-09-06

Last Posted Date: 2012-10-02

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT01680042

Locations: 🇮🇷
Shahid Beheshti Medical University, Tehran, Iran, Islamic Republic of
🇮🇷
Shaheed Beheshti University, Tehran, Iran, Islamic Republic of

Comparison of DASH With Oxalate Restricted Diet on Urine in Recurrent Stone Formers With Hyperoxaluria

Not Applicable

Completed

Conditions: Nephrolithiasis

Interventions: Behavioral: diet

First Posted Date: 2012-07-26

Last Posted Date: 2013-04-16

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 48

Registration Number: NCT01650935

Locations: 🇮🇷
Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of
🇮🇷
Labbafinejad Hospital, Tehran, Iran, Islamic Republic of

Vital Pulp Therapy (VPT) Using Calcium Enriched Mixture (CEM) to Treat Irreversible Pulpitis

Not Applicable

Completed

Conditions: Irreversible Pulpitis

Interventions: Procedure: Full pulpotomy (FP)
Procedure: Direct pulp capping (DPC)
Procedure: Indirect pulp capping (IPC)
Procedure: Miniature pulpotomy (MP)

First Posted Date: 2012-03-22

Last Posted Date: 2017-04-28

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 302

Registration Number: NCT01561183

Locations: 🇮🇷
Imam Khomeini Dental Clinic, Tehran, Iran, Islamic Republic of

Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

Phase 3

Completed

Conditions: Coronary Arteriosclerosis

Interventions: Drug: omega 3

First Posted Date: 2012-01-31

Last Posted Date: 2012-12-10

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 104

Registration Number: NCT01521845

Locations: 🇮🇷
Moddaress Hospital, Tehran, Iran, Islamic Republic of

Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial

Not Applicable

Completed

Conditions: Myopic Regression

Interventions: Drug: Placebo
Drug: Timolol

First Posted Date: 2012-01-10

Last Posted Date: 2012-01-10

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 45

Registration Number: NCT01506635

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Mitomycin-c Application for PRK

Not Applicable

Completed

Conditions: Myopia

Interventions: Drug: mitomycin-C
Drug: Placebo

First Posted Date: 2012-01-05

Last Posted Date: 2012-01-05

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT01504282

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)

Phase 3

Conditions: Disorder Related to Renal Transplantation

Interventions: Drug: N-acetyl Cysteine

First Posted Date: 2011-07-27

Last Posted Date: 2011-07-27

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT01403506

Locations: 🇮🇷
Department of Nephrology, Shahid Labbafinejad Medical Center and Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Effect of Consumption of Black Cumin (Nigella Sativa L.) Water Extract on Weight Loss in Overweight Women

Not Applicable

Withdrawn

Conditions: Obesity

Interventions: Dietary Supplement: Black cumin water extract as a traditional medicine

First Posted Date: 2011-05-26

Last Posted Date: 2015-11-18

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Registration Number: NCT01360957

Comparison of Intravitreal Bevacizumab and Triamcinolone With Placebo

Phase 1

Conditions: Acute Nonarteritic Anterior Ischemic Optic Neuropathy

Interventions: Other: placebo
Drug: Avastin and Triamcinolone

First Posted Date: 2011-04-07

Last Posted Date: 2011-04-07

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 16

Registration Number: NCT01330524

Locations: 🇮🇷
Labbafinejad medical center, Tehran, Iran, Islamic Republic of

Dexpanthenol Mouthwash to Treat Oral Mucositis

Phase 2

Conditions: Oral Mucositis (Ulcerative) Due to Radiation

Interventions: Drug: Dexpanthenol

First Posted Date: 2011-03-21

Last Posted Date: 2011-07-06

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 30

Registration Number: NCT01318889

Locations: 🇮🇷
ShaheedBeheshti medical university, Tehran, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy